Who owns KARO HEALTHCARE?

KARO HEALTHCARE has been 100% owned by KKR since August 2025.

At what enterprise value was KARO HEALTHCARE acquired in 2025?

During the acquisition of KARO HEALTHCARE by KKR in 2025, the transaction's Enterprise Value is estimated to be in the range of 1b - 4b EUR.

What was the EV/EBITDA of KARO HEALTHCARE when it was acquired by KKR?

The estimated EV/EBITDA multiple for KARO HEALTHCARE is in the range of 15x - 25x.

When was KARO HEALTHCARE acquired by KKR?

KARO HEALTHCARE was acquired by KKR in 2025.

What was the revenue of KARO HEALTHCARE at the time of the deal?

The revenue of KARO HEALTHCARE at the time of the deal is estimated to be in the range of 450M - 900M EUR.

What was the EBITDA of KARO HEALTHCARE during the acquisition?

KARO HEALTHCARE's EBITDA is estimated to be in the range of 100M - 200M EUR.

How is the data for the KARO HEALTHCARE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the KARO HEALTHCARE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.karohealthcare.com/karo-healthcare-announces-kkr-as-new-owner-following-successful-strategic-transformation-into-pan-european-consumer-healthcare-player/

What is the average EV/EBITDA multiple for the Retail & Consumer sector in 2026?

The average EV/EBITDA multiple for the Retail & Consumer sector in 2026 is 11.2x.

← DATABASE

Home Database Retail & ConsumerKARO HEALTHCARE

08/2025

KARO HEALTHCARE acquired by KKR

SWEDEN Consumer Products / Personal & Household / Hygiene & Beauty Brands EV 1b - 4b EUR

Context

KKR has finalized the 100% acquisition of Karo Healthcare from the EQT VIII fund in a transaction initially announced in April 2025. The strategic rationale for KKR is to capitalize on a pan-European platform already structured for significant scale. Following a period where revenues quadrupled under EQT, Karo is entering an international acceleration phase. KKR plans to leverage its global footprint to deepen Karo’s reach across new distribution channels and geographies, while continuing to consolidate the fragmented sector through targeted bolt-on acquisitions. The transaction was advised by Citigroup and J.P. Morgan for KKR, and Morgan Stanley and Jefferies for EQT.

KARO HEALTHCARE, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Retail & Consumer sector (11.2x).

-> Deep-dive in Retail & Consumer market trends

Target

Karo Healthcare is a leading European platform specialized in over-the-counter (OTC) consumer healthcare products. Under EQT's ownership, the company underwent a radical transformation, evolving from a Nordic specialty pharma player into a pan-European champion. Its portfolio focuses on trusted brands in resilient categories: Skin Health, Foot Health, Intimate Health, Digestive Health, and Vitamins, Minerals & Supplements (VMS). Present in over 90 countries, Karo relies on a highly digitized commercial platform and a mixed growth model combining organic performance with an aggressive "Buy-and-Build" strategy, evidenced by eight acquisitions completed since 2019.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Consumer Products

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
10/2025	FRENCH FOOD CAPITAL / BPIFRANCE	SABRE PARIS	FRANCE	Home & DIY
09/2025	PLATINUM EQUITY	XD CONNECTS	NETHERLANDS	Consumer Products
06/2025	PARTNERS GROUP	MPM	UNITED KINGDOM	Pet Care
06/2025	KONTOOR BRANDS	HELLY HANSEN	NORWAY	Fashion & Apparel
06/2025	PLATINUM EQUITY	SOLO GROUP	FRANCE	Consumer Products
05/2025	AUTHENTIC BRANDS GROUP	DOCKERS	UNITED STATES	Fashion & Apparel
04/2025	BRICONORD	SCELL-IT	FRANCE	Home & DIY
03/2025	USHOPAL GROUP	PAYOT	FRANCE	Hygiene & Beauty Brands
02/2025	BC PARTNERS	PETLAB	UNITED KINGDOM	Pet Care
01/2025	ACON Investments	True Religion	UNITED STATES	Fashion & Apparel

REFERENCES

Valuation range: EV 1b - 4b EUR

Revenue range: 450M - 900M EUR

EBITDA range: 100M - 200M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of KARO HEALTHCARE by KKR are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: kkr